Cargando…
Mutational mimics of allosteric effectors: a genome editing design to validate allosteric drug targets
Development of drugs that allosterically regulate enzyme functions to treat disease is a costly venture. Amino acid susbstitutions that mimic allosteric effectors in vitro will identify therapeutic regulatory targets enhancing the likelihood of developing a disease treatment at a reasonable cost. We...
Autores principales: | Tang, Qingling, Villar, Maria T., Artigues, Antonio, Thyfault, John P., Apte, Udayan, Zhu, Hao, Peterson, Kenneth R., Fenton, Aron W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6588628/ https://www.ncbi.nlm.nih.gov/pubmed/31227746 http://dx.doi.org/10.1038/s41598-019-45202-2 |
Ejemplares similares
-
AlloSigMA 2: paving the way to designing allosteric effectors and to exploring allosteric effects of mutations
por: Tan, Zhen Wah, et al.
Publicado: (2020) -
Modulation of hemoglobin dynamics by an allosteric effector
por: Lal, Jyotsana, et al.
Publicado: (2017) -
In Silico Prediction and Validation of CB2 Allosteric Binding Sites to Aid the Design of Allosteric Modulators
por: Yuan, Jiayi, et al.
Publicado: (2022) -
Thrombin A-Chain: Activation Remnant or Allosteric Effector?
por: Carter, Isis S. R., et al.
Publicado: (2010) -
Discovery of Novel Allosteric Effectors Based on the Predicted Allosteric Sites for Escherichia coli D-3-Phosphoglycerate Dehydrogenase
por: Wang, Qian, et al.
Publicado: (2014)